The Multiple Myeloma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Luciano Costa | ASCO 2018 | Phase II study of venetoclax, carfilzomib and dexamethasone in RRMM

Jun 3, 2018

ASCO Annual Meeting, 1-5 June 2018, Chicago, IL

Luciano Costa
University of Alabama Comprehensive Cancer Center, Birmingham, US

Interview topic: Luciano Costa | ASCO 2018 | Phase II study of venetoclax, carfilzomib and dexamethasone in RRMM

Phase II study of venetoclax, carfilzomib and dexamethasone in RRMM